Cart
sales@molnova.com
Phe-Lys(Trt)-PAB
CAS No. 1116085-99-4
Phe-Lys(Trt)-PAB ( —— )
Catalog No. M27000 CAS No. 1116085-99-4
Phe-Lys(Trt)-PAB is a cathepsin cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 120 | Get Quote |
|
| 10MG | 170 | Get Quote |
|
| 25MG | 308 | Get Quote |
|
| 50MG | 439 | Get Quote |
|
| 100MG | 627 | Get Quote |
|
| 200MG | 897 | Get Quote |
|
| 500MG | 1332 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePhe-Lys(Trt)-PAB
-
NoteResearch use only, not for human use.
-
Brief DescriptionPhe-Lys(Trt)-PAB is a cathepsin cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
-
DescriptionPhe-Lys(Trt)-PAB is a cathepsin cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).(In Vitro):ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1116085-99-4
-
Formula Weight640.8
-
Molecular FormulaC41H44N4O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN[C@@H](Cc1ccccc1)C(=O)N([C@@H](CCCCNC(c1ccccc1)(c1ccccc1)c1ccccc1)C(N)=O)c1ccc(CO)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.de Veth MJ, et al. Choline absorption and evaluation of bioavailability markers when supplementing choline to lactating dairy cows. J Dairy Sci. 2016 Dec;99(12):9732-9744.
molnova catalog
related products
-
3-O-Methylviolanone
3'-O-methylviolanone has anti-inflammatory activity.
-
Benzoylhypacoitine
Benzoylhypacoitine might be the principal active components which affect mitochondrial growth by Fuzi and its processed products.
-
NH2-C4-NH-Boc
NH2-C4-NH-Boc (compound 15) is a PROTAC linker belonging to the Alkyl/ether class. NH2-C4-NH-Boc can be used to synthesize a series of PROTAC molecules.
